Active

    Aragen Life Sciences Limited

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Aragen Life Sciences Limited IPO Details

    Listing Date

    -

    Bid Price

    ₹0 - ₹0

    Lot Size

    0 Shares

    Minimum Investment

    ₹

    Issue Size

    ₹0 Cr

    Key Dates to Track

        Here are the important dates you need to know in order to participate in this IPO

    tick

    Offer Start Date

    -

    tick

    Offer End Date

    -

    tick

    Allotment Date

    -

    tick

    Refund Initiation

    -

    tick

    Demat Transfer

    -

    tick

    Listing Date

    -

    Aragen Life Sciences Limited Shareholding Pattern

      Pre-Issue Post-Issue
    Promoter Group 0% 0%
    Public Group 100% 100%

    Aragen Life Sciences Limited IPO Reservation

    QIB Shares Offered 0 (0%)
    NII (HNI) Shares Offered 0 (0%)
    Retail Shares Offered 0 (0%)
    Anchor Investor Shares Offered 0 (0%)
    Total Shares Offered 0
    Total Shares With Anchor Investor 0

    Aragen Life Sciences Limited IPO Lot Size

    Application Lots Shares Amount
    Retail (Min) [-] [-] ₹[-]
    Retail (Max) [-] [-] ₹[-]
    S HNI (Min) [-] [-] ₹[-]
    S HNI (Max) [-] [-] ₹[-]
    B HNI (MIN) [-] [-] ₹[-]

    Aragen Life Sciences Limited IPO registrar

    KFin Techologies Ltd
    Phone Number 91 40 67162222/180 03094001
    Email Id aragenlifesciences.ipo@kfintech.com
    Website www.kfintech.com

    Aragen Life Sciences Limited IPO Lead Manager

    1. Axis Capital Limited

    2. Citigroup Global Markets India Private Limited

    3. Goldman Sachs (India) Securities Private Limited^

    4. JM Financial Limited

    Aragen Life Sciences Limited Financial Information

    March 31, 2025 March 31, 2024 March 31, 2023
    Net Worth ₹2,057.38 Cr ₹1,304.55 Cr ₹1,175.15 Cr
    Reserves and Surplus ₹1,840.39 Cr ₹1,100.13 Cr ₹970.74 Cr
    Total Borrowing ₹477.48 Cr ₹645.47 Cr ₹528.54 Cr

    Strength of Aragen Life Sciences Limited

    • Largest Indian CRDMO platform offering comprehensive solutions across the drug development lifecycle for both small molecules and biologics with a "follow the customer" model.
    • Leading CRO platform in India powered by advanced capabilities and superior scientific talent.
    • Scalable CDMO solutions comprising small molecules and differentiated gene-to-GMP biologics capabilities with a distinctive US-India delivery model.
    • Diversified revenue profile with deep and long-standing relationships with global pharmaceutical customers and proven `Follow the customer' model
    • Strategically located advanced infrastructure across India and United states with strong track record of regulatory compliance.
    • Professional management for long term sustainable performance.

    Risks Involved

    • The company is dependent on the continued outsourcing of research and development by innovator pharmaceutical and biotechnology companies. The company derived a substantial portion of its revenue from operations from the company CRO solutions in Fiscals 2026, 2025 and 2024 representing 64.51%, 65.78% and 67.15%, respectively, of its revenue from operations. Any adverse trends in the outsourcing practices or reduction in demand for outsourcing by innovator pharmaceutical and biotechnology companies could adversely affect the company's business, results of operations, cash flows and financial condition.
    • The company derives a significant portion of its revenue from operations from customers outside India, particularly from North America and Europe. While revenue from operations from North America represented 54.80%, 60.08% and 55.19% of the company's revenue from operations in Fiscals 2026, 2025 and 2024, respectively, revenue from operations from Europe represented 29.67%, 22.24% and 27.19% of its revenue from operations in Fiscals 2026, 2025 and 2024, respectively. Any adverse developments in these international markets could impact the demand for the company's solutions which in turn could have an adverse effect on its business, financial condition, cash flows and results of operations.
    • The company depends on certain key customers for a significant portion of its revenue from operations (the company's top ten customers contributed to 43.29%, 35.41% and 31.36% of its revenue from operations in Fiscals 2026, 2025 and 2024, respectively). Any decrease in revenue from any of the company's key customers or any loss of these customers may adversely affect its business, results of operations, cash flows and financial condition.
    • The company is subject to strict technical specifications and quality requirements, and its manufacturing facilities and equipment are subject to periodic inspections and audits by regulatory authorities and the company's customers. Any manufacturing or quality control failures may subject it to regulatory action or termination of customer contracts any of which could have an adverse effect on the company's reputation, business, results of operations, cash flows and financial condition.
    • The company is highly dependent on its skilled personnel, in particular the company's scientific personnel, for its day-to-day operations. The loss of, or the company's inability to attract or retain such persons may have a material adverse effect on its business, results of operations, cash flows and financial condition.
    • Any inability of the company's customers to develop or manufacture commercially viable drugs may adversely affect outsourcing needs and its development and manufacturing revenue and consequently, the company's business, financial condition, results of operations and cash flows.
    • The company R&D and manufacturing facilities are essential to its business. Any disruption or interruption in the continuous operations of the company R&D and manufacturing facilities would have a material adverse effect on its business, results of operations, cash flows and financial condition.
    • The company compete in a highly competitive market and any failures to successfully compete with other industry players or to maintain pricing discipline in the faces of competitive pressures could materially adversely affect its margins, business, results of operations, cash flows and financial condition.
    • The company failures to protect its customers trade secrets, sensitive information and other confidential information, or any infringement or misappropriation claims, could erode the company competitive advantage and adversely affect its reputation, business, results of operations, cash flows and financial condition.
    • The company relies on domestic and international third-party suppliers for its raw materials that contribute to a significant portion of the company's total purchases (its top ten suppliers contributed to 32.91%, 33.73% and 27.56% of the company's total purchases in Fiscals 2026, 2025 and 2024, respectively). Any inability to retain key suppliers or identify alternate sourcing arrangements for critical raw materials could adversely affect the company's business, results of operations, cash flows and financial condition.

    Invest in IPOs with ease

    Sign-in to invest with your demat account, or set up a new demat account for free

    Explore Other IPOs

    • Current IPOs
    • Upcoming IPOs
    • Closed IPOs
    • IPO Performance
    • All
    • MainBoard
    • SME
    CORE4 ENGINEERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    23rd Oct 2026 - 10th Oct 2026
    Price Range
    ₹88.0 - 93.0
    IPO Size
    ₹54,82,00,000
    • All
    • MainBoard
    • SME
    Bidding Period
    26th Oct 2026 - 10th Oct 2026
    Price Range
    ₹1585.0 - 1665.0
    IPO Size
    ₹12,00,00,00,000
    BLS Polymers Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹142.0 - 150.0
    IPO Size
    ₹2,55,00,00,128
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹313.0 - 330.0
    IPO Size
    ₹6,67,53,00,352
    Wiscon Industries Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹194.0 - 204.0
    IPO Size
    ₹1,10,00,00,000
    Carver Roboweld Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    28th Oct 2026 - 10th Oct 2026
    Price Range
    ₹76.0 - 80.0
    IPO Size
    ₹0
    Bidding Period
    29th Oct 2026 - 11th Nov 2026
    Price Range
    ₹78.0 - 82.0
    IPO Size
    ₹1,83,05,99,936
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanced SysTek Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanta Enterprises Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Agilus Diagnostics Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AGS Health Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Airox Technologies Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AITMC Ventures Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Ajay Poly Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Allchem Lifescience Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    NO ACTIVE IPO HERE
    • All
    • MainBoard
    • SME
    JIO PLATFORMS LIMITED IPO
    icon
    Closing Today
    SME IPO
    Early Access
    Bidding Period
    21st Oct 2026 - 10th Oct 2026
    Price Range
    ₹1065.0 - 1119.0
    IPO Size
    ₹3,02,13,00,03,968
    PARAS HEALTHCARE LIMITED IPO
    icon
    Closing Today
    SME IPO
    Early Access
    Bidding Period
    21st Oct 2026 - 10th Oct 2026
    Price Range
    ₹660.0 - 693.0
    IPO Size
    ₹14,49,99,99,744
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹327.0 - 344.0
    IPO Size
    ₹4,75,48,00,128
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹558.0 - 586.0
    IPO Size
    ₹25,33,80,99,712
    SHELLZ INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹170.0 - 179.0
    IPO Size
    ₹59,97,00,032
    TONBO IMAGING INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹665.0 - 700.0
    IPO Size
    ₹8,52,17,99,680
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹143.0 - 151.0
    IPO Size
    ₹50,12,33,00,864
    FUSION CX LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    14th Oct 2026 - 10th Oct 2026
    Price Range
    ₹275.0 - 289.0
    IPO Size
    ₹7,02,00,00,256
    Bidding Period
    14th Oct 2026 - 10th Oct 2026
    Price Range
    ₹105.0 - 112.0
    IPO Size
    ₹1,16,04,99,968
    HD FIRE PROTECT LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    13th Oct 2026 - 10th Oct 2026
    Price Range
    ₹258.0 - 271.0
    IPO Size
    ₹7,12,12,99,968
    VAIBHAV VYAPAAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    13th Oct 2026 - 10th Oct 2026
    Price Range
    ₹51.0 - 54.0
    IPO Size
    ₹42,10,00,000
    Bidding Period
    5th Oct 2026 - 10th Oct 2026
    Price Range
    ₹77.0 - 82.0
    IPO Size
    ₹34,99,00,032
    PARAMOUNT SYNTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹119.0 - 127.0
    IPO Size
    ₹81,79,00,032
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹186.0 - 196.0
    IPO Size
    ₹1,21,68,99,968
    TNA SOLUTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹66.0 - 70.0
    IPO Size
    ₹37,86,00,000
    VISHAL NIRMITI LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹208.0 - 220.0
    IPO Size
    ₹1,78,00,00,000
    SHREE TNB POLYMERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    28th Sep 2026 - 10th Oct 2026
    Price Range
    ₹50.0 - 53.0
    IPO Size
    ₹31,80,00,000
    SJP ULTRASONICS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹67.0 - 67.0
    IPO Size
    ₹23,45,00,000
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹55.0 - 55.0
    IPO Size
    ₹21,78,00,000
    EVENTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹112.0 - 118.0
    IPO Size
    ₹38,12,00,000
    • All
    • MainBoard
    • SME
    Issue Prize
    1785.00
    Listing Day Close
    1818.00(1.85%)
    LAPL AUTOMOTIVE LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    94.00
    Listing Day Close
    128.29(36.17%)
    FUSION CX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    289.00
    Listing Day Close
    289.75(0.35%)
    HD FIRE PROTECT LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    271.00
    Listing Day Close
    307.20(13.28%)
    Issue Prize
    112.00
    Listing Day Close
    113.70(1.79%)
    VAIBHAV VYAPAAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    54.00
    Listing Day Close
    53.05(-1.85%)
    Issue Prize
    82.00
    Listing Day Close
    76.00(-7.32%)
    PARAMOUNT SYNTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    127.00
    Listing Day Close
    109.25(-14.17%)
    Issue Prize
    196.00
    Listing Day Close
    232.05(18.37%)
    TNA SOLUTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    70.00
    Listing Day Close
    58.80(-15.71%)
    VISHAL NIRMITI LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    220.00
    Listing Day Close
    204.25(-7.27%)
    SHREE TNB POLYMERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    53.00
    Listing Day Close
    57.00(7.55%)
    SJP ULTRASONICS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    67.00
    Listing Day Close
    73.01(8.96%)
    Issue Prize
    55.00
    Listing Day Close
    99.18(80.00%)
    EVENTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    118.00
    Listing Day Close
    105.45(-11.02%)
    Issue Prize
    85.00
    Listing Day Close
    119.70(41.18%)
    Issue Prize
    75.00
    Listing Day Close
    84.15(12.00%)
    OMARA VENTURES INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    311.00
    Listing Day Close
    319.05(2.57%)
    Issue Prize
    72.00
    Listing Day Close
    68.75(-4.17%)
    GREEN ASIA IMPEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    89.00
    Listing Day Close
    84.55(-4.49%)

    Frequently Asked Questions

    What is Aragen Life Sciences Limited IPO?

    Aragen Life Sciences Limited IPO is a IPO of [-] equity shares of a face value of ₹[-] aggregating up to ₹[-] Crores. The issue is priced at ₹[-] to ₹[-] per share. The minimum order quantity is [-] Shares. The IPO opens on [-], and closes on [-]. KFin Techologies Ltd is the registrar for the IPO. The shares are proposed to be listed on .

    When Aragen Life Sciences Limited IPO will open?

    The Aragen Life Sciences Limited IPO opens on [-] and closes on [-].

    What is the lot size of Aragen Life Sciences Limited?

    Aragen Life Sciences Limited lot size is [-] shares, and the minimum amount required is ₹[-].

    How to apply for Aragen Life Sciences Limited IPO?

    You can apply in Aragen Life Sciences Limited IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

    • Login to Bajaj Broking account App/Website & click on IPO
    • Enter the number of lots and price at which you wish to apply.
    • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
    • You will receive a mandate notification to block funds in your UPI app.
    • Approve the mandate request on your UPI and funds will be blocked.

    When is Aragen Life Sciences Limited IPO allotment?

    The finalization of Basis of Allotment for Aragen Life Sciences Limited IPO will be done on [-], and the allotted shares will be credited to your demat account by [-].

    When is Aragen Life Sciences Limited IPO listing date?

    The Aragen Life Sciences Limited listing date is [-].

    Who is the registrar of Aragen Life Sciences Limited IPO?

    The registrar of Aragen Life Sciences Limited IPO is KFin Techologies Ltd

    Which company is the book-running lead manager of the IPO?

    Axis Capital Limited,Citigroup Global Markets India Private Limited,Goldman Sachs (India) Securities Private Limited^,JM Financial Limited will be the book-running lead manager of this IPO.

    What is the fresh issue of Aragen Life Sciences Limited IPO?

    The fresh issue size is ₹[-] Crores equity shares.

    What minimum lot size can retail subscribers subscribe to Aragen Life Sciences Limited?

    Retail investors can subscribe to a minimum of one lot, [-] shares and ₹[-] amount.

    How can I approve the UPI mandate request for Aragen Life Sciences Limited IPO?

    To apply for Aragen Life Sciences Limited IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

    What is the price range of Aragen Life Sciences Limited?

    The price of each Aragen Life Sciences Limited share will be ranging in between ₹[-] to ₹[-] per share.

    What is the cut-off time for the UPI mandate for Aragen Life Sciences Limited IPO?

    The cut-off time for the UPI mandate confirmation is 5:00 PM, [-].

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |